Sun Pharma.Inds.

{
  "main_header": {
    "sid": 948699,
    "name": "Sun Pharma.Inds.",
    "stock_name": "Sun Pharma.Inds.",
    "full_name": "Sun Pharmaceutical Industries Ltd",
    "name_url": "stocks-analysis/sun-pharmainds",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,912.05",
    "chg": -1,
    "chgp": "-0.05%",
    "dir": -1,
    "prev_price": "1,913.05",
    "mcapval": "458,764.84 Cr",
    "mcap": "Large Cap",
    "scripcode": 524715,
    "symbol": "SUNPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE044A01036",
    "curr_date": "Jul 07, 11:05 AM",
    "curr_time": "11:06 AM",
    "last_traded_at": "Jul 07, 11:05 AM IST",
    "bse_nse_vol": "5.6 lacs",
    "exc_status": "Active",
    "traded_date": "Jul 07, 2026",
    "traded_date_str": "2026 07 07",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sun-pharmainds-948699-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MS",
      "url": "https://www.marketsmojo.com/mojostocks#!#top10",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sun-pharmainds-948699-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "P/E at 36.87 vs Industry's 35.74: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-nifty-50-membership-and-institutional-dynamics-shape-market-outlook-4091846",
        "imagepath": "",
        "date": "2026-07-07 09:20:59",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Premium Amidst Sector Parity</strong></p>\n                <p>The current P/E of <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> stands at 36.87, slightly above the Pharmaceuticals & Biotechnology industry average of 35.74. This premium, though not excessive, suggests that the market is pricing in expectations of steady earnings growth or superior operational performance relative to peers. The company’s large-cap status, with a market capitalisation of approximately ₹4,57,493 crore, supports this valuation level, reflecting its established position within the sector.</p>\n                <p>However, valuation alone does not tell the full story — <a href=\"https://www.marketsmojo.c..."
      },
      {
        "title": "P/E at 36.66 vs Industry's 35.59: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-a-pillar-of-strength-in-the-nifty-50-amid-institutional-shifts-4090227",
        "imagepath": "",
        "date": "2026-07-06 09:21:08",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Premium Amidst Sector Parity</strong></p>\n                <p>The P/E ratio of 36.66 for <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> is just above the sector average of 35.59, indicating a modest valuation premium of approximately 3%. This premium suggests that the market attributes slightly higher earnings quality or growth prospects to the company compared to its industry peers. However, the difference is not stark, implying that valuation remains broadly in line with sector norms. The company’s large-cap status, with a market capitalisation of ₹4,56,989 crores, supports this valuation stance, reflecting its established position within the Pharmaceuticals & Biotechnology s..."
      },
      {
        "title": "Sun Pharmaceutical Gains 1.71%: 6 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-gains-171-6-key-factors-driving-the-weeks-momentum-4088751",
        "imagepath": "",
        "date": "2026-07-04 14:04:41",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>29 Jun:</strong> Surge in call option activity ahead of June expiry</p>\n                    <p><strong>30 Jun:</strong> Significant open interest increase amid bullish positioning</p>\n                    <p><strong>1 Jul:</strong> Continued open interest surge with positive price momentum</p>\n                    <p><strong>3 Jul:</strong> New 52-week high at Rs 1919.7 and mixed options activity</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,872.60</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class..."
      },
      {
        "title": "Rs 1,900 Puts — Just Below Current Price — Draw 4,257 Contracts on Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-sees-surge-in-put-option-activity-amid-bullish-price-momentum-4087821",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SunPharmaceutic_most_active_stocks_puts_4087821.png",
        "date": "2026-07-03 12:00:07",
        "description": "The stock is trading at Rs 1,914.20, just above the Rs 1,900 put strike where 4,257 contracts changed hands on 3 July 2026. This close proximity between strike and underlying price suggests the put activity is more nuanced than a straightforward bearish bet."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Sun Pharmaceutical Industries Ltd to 52-Week High of Rs 1919.7",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-hits-new-52-week-high-at-rs-19197-4087780",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SunPharmaceutic_priceRelatedfactors_4087780.png",
        "date": "2026-07-03 11:11:35",
        "description": "With a decisive surge to Rs 1919.7 on 3 Jul 2026, Sun Pharmaceutical Industries Ltd has reached a fresh 52-week high, extending its upward momentum amid a broadly positive market backdrop."
      },
      {
        "title": "Rs 1900 Calls on Sun Pharmaceutical Industries Ltd See Heavy Activity — What the Strike Price Tells You",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-sees-surge-in-call-option-activity-ahead-of-july-expiry-4087527",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SunPharmaceutic_most_active_stocks_calls_4087527.png",
        "date": "2026-07-03 10:00:26",
        "description": "4,102 call contracts at the Rs 1900 strike traded on 3 Jul 2026, with Sun Pharmaceutical Industries Ltd closing at Rs 1904.20, just above the strike price. This alignment between the options strike and the underlying price highlights a focused directional bet as the stock edges closer to its 52-week high."
      },
      {
        "title": "P/E at 36.01 vs Industry's 35.12: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-strengthens-position-as-a-key-nifty-50-constituent-amid-institutional-interest-4087167",
        "imagepath": "",
        "date": "2026-07-03 09:21:57",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Premium Reflects Confidence Amid Sector Parity</strong></p>\n                <p>The current P/E of <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> stands at 36.01, slightly above the Pharmaceuticals & Biotechnology industry average of 35.12. This 2.5% premium suggests investors are willing to pay a marginally higher price for earnings, reflecting expectations of relative stability or growth within a sector that has seen mixed results. The premium is not excessive but indicates a degree of confidence in the company’s earnings quality and future prospects. <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharma</a>’s market capitalisa..."
      },
      {
        "title": "Sun Pharmaceutical Industries Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sun-pharmaceutical-industries-ltd-is-rated-buy-4084701",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SunPharmaceutic_mojoScore_4084701.png",
        "date": "2026-07-02 10:10:53",
        "description": "Sun Pharmaceutical Industries Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 July 2026, providing investors with the most up-to-date insight into the company’s performance and outlook."
      },
      {
        "title": "P/E at 35.98 vs Industry's 34.99: What the Data Shows for Sun Pharmaceutical Industries Ltd",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-strengthens-position-as-key-nifty-50-constituent-amid-robust-institutional-interest-4084300",
        "imagepath": "",
        "date": "2026-07-02 09:21:16",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Valuation Picture: Slight Premium Reflects Market Confidence</strong></p>\n                <p>The current P/E of 35.98 represents a modest premium of approximately 2.8% over the industry average of 34.99. This premium suggests that investors are willing to pay slightly more for <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> relative to its peers, possibly reflecting expectations of stable earnings growth or superior market positioning. However, the premium is not excessive, indicating that valuation remains broadly in line with sector norms. The market capitalisation of Rs 4,50,007.27 crore firmly places the company in the large-cap category, underscoring its established presence in the Pharmaceu..."
      }
    ],
    "total": 1177,
    "sid": "948699",
    "stock_news_url": "https://www.marketsmojo.com/news/sun-pharmaceutical-industries-948699"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "26-Jun-2026",
      "details": "Newspaper Advertisement",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Jun-2026",
      "details": "Closure of trading window",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
      "datetime": "20-Jun-2026",
      "details": "Acquisition of Innovcare Lifesciences Private Limited",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has declared <strong>500%</strong> dividend, ex-date: 07 Jul 26",
          "dt": "2026-07-07",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:5</strong> stock split, ex-date: 25 Nov 10",
          "dt": "2010-11-25",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 29 Jul 13",
          "dt": "2013-07-29",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

P/E at 36.87 vs Industry's 35.74: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-07-07 09:20:59

Valuation Picture: Premium Amidst Sector Parity

The current P/E of Sun Pharmaceutical Industries Ltd stands at 36.87, slightly above the Pharmaceuticals & Biotechnology industry average of 35.74. This premium, though not excessive, suggests that the market is pricing in expectations of steady earnings growth or superior operational performance relative to peers. The company’s large-cap status, with a market capitalisation of approximately ₹4,57,493 crore, supports this valuation level, reflecting its established position within the sector.

However, valuation alone does not tell the full story — Read full news article

P/E at 36.66 vs Industry's 35.59: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-07-06 09:21:08

Valuation Picture: Premium Amidst Sector Parity

The P/E ratio of 36.66 for Sun Pharmaceutical Industries Ltd is just above the sector average of 35.59, indicating a modest valuation premium of approximately 3%. This premium suggests that the market attributes slightly higher earnings quality or growth prospects to the company compared to its industry peers. However, the difference is not stark, implying that valuation remains broadly in line with sector norms. The company’s large-cap status, with a market capitalisation of ₹4,56,989 crores, supports this valuation stance, reflecting its established position within the Pharmaceuticals & Biotechnology s...

Read full news article

Sun Pharmaceutical Gains 1.71%: 6 Key Factors Driving the Week’s Momentum

2026-07-04 14:04:41

Key Events This Week

29 Jun: Surge in call option activity ahead of June expiry

30 Jun: Significant open interest increase amid bullish positioning

1 Jul: Continued open interest surge with positive price momentum

3 Jul: New 52-week high at Rs 1919.7 and mixed options activity

Week Open

Rs.1,872.60

Week Close

Read full news article

Rs 1,900 Puts — Just Below Current Price — Draw 4,257 Contracts on Sun Pharmaceutical Industries Ltd

2026-07-03 12:00:07

The stock is trading at Rs 1,914.20, just above the Rs 1,900 put strike where 4,257 contracts changed hands on 3 July 2026. This close proximity between strike and underlying price suggests the put activity is more nuanced than a straightforward bearish bet.

Read full news article

Broad-Based Technical Strength Lifts Sun Pharmaceutical Industries Ltd to 52-Week High of Rs 1919.7

2026-07-03 11:11:35

With a decisive surge to Rs 1919.7 on 3 Jul 2026, Sun Pharmaceutical Industries Ltd has reached a fresh 52-week high, extending its upward momentum amid a broadly positive market backdrop.

Read full news article

Rs 1900 Calls on Sun Pharmaceutical Industries Ltd See Heavy Activity — What the Strike Price Tells You

2026-07-03 10:00:26

4,102 call contracts at the Rs 1900 strike traded on 3 Jul 2026, with Sun Pharmaceutical Industries Ltd closing at Rs 1904.20, just above the strike price. This alignment between the options strike and the underlying price highlights a focused directional bet as the stock edges closer to its 52-week high.

Read full news article

P/E at 36.01 vs Industry's 35.12: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-07-03 09:21:57

Valuation Picture: Premium Reflects Confidence Amid Sector Parity

The current P/E of Sun Pharmaceutical Industries Ltd stands at 36.01, slightly above the Pharmaceuticals & Biotechnology industry average of 35.12. This 2.5% premium suggests investors are willing to pay a marginally higher price for earnings, reflecting expectations of relative stability or growth within a sector that has seen mixed results. The premium is not excessive but indicates a degree of confidence in the company’s earnings quality and future prospects. Sun Pharma’s market capitalisa...

Read full news article

Sun Pharmaceutical Industries Ltd is Rated Buy

2026-07-02 10:10:53

Sun Pharmaceutical Industries Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 08 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 July 2026, providing investors with the most up-to-date insight into the company’s performance and outlook.

Read full news article

P/E at 35.98 vs Industry's 34.99: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-07-02 09:21:16

Valuation Picture: Slight Premium Reflects Market Confidence

The current P/E of 35.98 represents a modest premium of approximately 2.8% over the industry average of 34.99. This premium suggests that investors are willing to pay slightly more for Sun Pharmaceutical Industries Ltd relative to its peers, possibly reflecting expectations of stable earnings growth or superior market positioning. However, the premium is not excessive, indicating that valuation remains broadly in line with sector norms. The market capitalisation of Rs 4,50,007.27 crore firmly places the company in the large-cap category, underscoring its established presence in the Pharmaceu...

Read full news article

View All News